drugs

  1. Walgreens acquires pharmacy files from Fred's

    Walgreens to buy pharmacy files from 185 Fred's stores for $165 million. Walgreens will be strengthening their presence in Southeastern US through this deal. https://news.alphastreet.com/walgreens-acquires-freds-inc-pharmacy-165-million/
  2. Merck joins pharma giants in lowering drug prices

    The latest pharma giant to bow to Trump’s pressure on drug price is Merck (MRK). The company announced on Thursday that it would lower price on at least six of its drug in the US by 10% or more. https://news.alphastreet.com/merck-joins-pharma-giants-in-lowering-drug-prices/
  3. Celgene gets a booster shot from recent trial results

    In the past two weeks, Celgene has reported positive results from 3 clinical trials. This includes two studies with its partner Acceleron. https://news.alphastreet.com/celgene-gets-a-booster-shot-from-recent-positive-clinical-trial-results/
  4. Trump slams Pfizer and other drugmakers

    Trump has been speaking and tweeting about the higher drug prices for nearly two years and still he has not taken any steps in reducing the prices of the drugs. Pfizer and other pharma companies are taking advantage and increasing their drug prices often. When will this stop...
  5. Amazon enters into healthcare space

    Amazon has entered into healthcare space by acquiring online pharmacy Pillpack. This will be a real blow for drugstore companies like Walgreens, Rite Aid, CVS Health and many more. So, will they deliver drugs through online orders without prescriptions or will they have some restrictions...
  6. Dermira's fatal fall !

    https://news.alphastreet.com/dermira-suffers-a-fatal-fall-after-catastrophic-trial-fail/ Shares of the skin specialist tanked almost 60% on Monday after the company announced that its closely-watched experimental acne drug failed to meet the objectives of two phase 3 clinical trials.
  7. Not so good looking results for Gilead

    GILD revenue down 13%; profit down 18%; product sales down 14%. Poor sales of hepatitis C drugs with lower sales predicted for the year. Hope the $12 bln acqusition of Kite Pharma should help the company.
  8. Alexion's Soliris sales up 4%

    Alexion's Soliris (eculizumab) product sales up 4% to $756 mil during the September quarter. Hope the FDA approval for Soliris for Myasthenia Gravis patients will boost the sales in the coming months. My granny has this disorder. I don't know when this drug will be available in the market?
  9. Amgen sees sales fall in some of its biggest established products

    https://alphastreet.com/bite/d578727 Amgen, that is in the process of refreshing its product portfolio, reported higher-than-expected 3Q profit, but sales declined in some of its biggest established products.
  10. Amgen sees sales fall in some of its biggest established products

    https://alphastreet.com/bite/d578727 Amgen, that is in the process of refreshing their product portfolios, reported higher-than-expected 3Q profit, but sales declined in some of its biggest established products.
  11. FDA to do priority review for Avycaz

    FDA to do a priority review for Avycaz and take action in first quarter of 2018.
  12. FDA approves Verzenio

    FDA says okay to Eli Lilly's breast cancer drug Verzenio.
  13. Anonymous Sources Wanted - Alabama Drug Reps/Marketers or distributors

    Hey Folks, I'm a journalist working for a large Alabama media company. I'm currently looking to speak with drug reps, marketers or distributors that have been involved in the process of selling opioid type drugs in Alabama. Your anonymity is guaranteed. My request is hot-on-the-heels of the...
  14. FDA halts Celgene

    Celgene forced to pause 5 trials using AstraZeneca’s Imfinzi and full hold on one trial.
  15. Lilly to present data at IHC

    Lilly to present new data at IHC for its migraine drugs Galcanezumab and Lasmiditan.
  16. Allergan patent litigation

    Allergan reaches a settlement with Famy Care and it will grant Famy Care a license to market generic version of Restasis in U.S. in 2024.
  17. Cialis drug's "erectile dysfunction"

    Cialis, a drug that is used to treat impotence, was given for a free trial for the first time users in 2004. Now the patent for Cialis expires earlier than the previous date.
  18. PAR South Will Be Sold Off

    PAR South to be sold off. At least that's what it's looking like for everyone down in Alabama. Executive leadership does not understand how to handle high volume products. They fired a sales force to protect the ones at the PAR North facilities and volume is down 60% on every product. That...